These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11294573)

  • 1. Small, dense low density lipoprotein (LDL) and the insulin resistance syndrome (IRS).
    Festa A
    Clin Lab; 2001; 47(3-4):111-8. PubMed ID: 11294573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein size and cardiovascular risk assessment.
    Rizzo M; Berneis K
    QJM; 2006 Jan; 99(1):1-14. PubMed ID: 16371404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of low-density-lipoproteins size in vascular diseases.
    Rizzo M; Berneis K; Corrado E; Novo S
    Int Angiol; 2006 Mar; 25(1):4-9. PubMed ID: 16520717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small, dense low-density-lipoproteins and the metabolic syndrome.
    Rizzo M; Berneis K
    Diabetes Metab Res Rev; 2007 Jan; 23(1):14-20. PubMed ID: 17080469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we measure routinely the LDL peak particle size?
    Rizzo M; Berneis K
    Int J Cardiol; 2006 Feb; 107(2):166-70. PubMed ID: 16412793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and small, dense low-density lipoprotein particles: cross-sectional study.
    Urahama N; Iguchi G; Shimizu M; Fujihira K; Kobayashi S; Baba H
    Nicotine Tob Res; 2008 Aug; 10(8):1391-5. PubMed ID: 18686187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease.
    Packard CJ
    Curr Opin Lipidol; 2006 Aug; 17(4):412-7. PubMed ID: 16832165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
    Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S
    Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.
    Rizzo M; Pernice V; Frasheri A; Di Lorenzo G; Rini GB; Spinas GA; Berneis K
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):870-5. PubMed ID: 18771560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
    McLaughlin T; Reaven G; Abbasi F; Lamendola C; Saad M; Waters D; Simon J; Krauss RM
    Am J Cardiol; 2005 Aug; 96(3):399-404. PubMed ID: 16054467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
    Sjögren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius ML; Fisher RM
    Metabolism; 2008 Mar; 57(3):362-6. PubMed ID: 18249208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic differences in the formation of small LDL particles in Asians: a comparison of Koreans, Japanese and Mongolians.
    Anuurad E; Shiwaku K; Enkhmaa B; Nogi A; Kitajima K; Yamasaki M; Yamane Y
    Eur J Clin Invest; 2004 Nov; 34(11):738-46. PubMed ID: 15530146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who needs to care about small, dense low-density lipoproteins?
    Rizzo M; Berneis K
    Int J Clin Pract; 2007 Nov; 61(11):1949-56. PubMed ID: 17935554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance.
    Julius U; Dittrich M; Pietzsch J
    Int J Clin Pract; 2007 Nov; 61(11):1798-804. PubMed ID: 17935544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders in high-density metabolism with insulin resistance and chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2007 Jan; 17(1):4-8. PubMed ID: 17198924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.